InChI=1S/C22H32O4/c1- 2- 3- 12- 15- 20(23) 16- 13- 10- 8- 6- 4- 5- 7- 9- 11- 14- 17- 21(24) 18- 19- 22(25) 26/h3- 5,8- 14,16- 17,20- 21,23- 24H,2,6- 7,15,18- 19H2,1H3,(H,25,26) /b5- 4- ,10- 8- ,11- 9- ,12- 3- ,16- 13+,17- 14+/t20- ,21+/m0/s1 |
JKPUWSZSJINVLB-OSKNXYPTSA-N |
C(C(O)=O)C[C@@H](/C=C/C=C\C/C=C\C/C=C\C=C\[C@H](C/C=C\CC)O)O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
(via resolvin )
|
|
anti-inflammatory agent
Any compound that has anti-inflammatory effects.
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
(via resolvin )
|
|
View more via ChEBI Ontology
(4S,5E,7Z,10Z,13Z,15E,17S,19Z)- 4,17- dihydroxydocosa- 5,7,10,13,15,19- hexaenoic acid
|
(4S,5E,7Z,10Z,13Z,15E,17S,19Z)- 4,17- dihydroxydocosahexaenoic acid
|
ChEBI
|
4S,17S-dihydroxy-5E,7Z,10Z,13Z,15E,19Z-docosahexaenoic acid
|
LIPID MAPS
|
RvD6
|
SUBMITTER
|
14535278
|
Reaxys Registry Number
|
Reaxys
|
|